Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Avolta €500 million notes offering and cash tender offer
We advised Avolta on its high-yield notes offering and tender offer
Morgan Stanley $8 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Barratt Developments £2.52 billion all-share offer for Redrow
We are advising UBS as financial adviser and sponsor to Barratt Developments on the transaction
Circle smart contract for real-time transfers of new tokenized BlackRock fund
We advised Circle on launching a smart contract enabling transfers of BlackRock’s tokenized fund over the Ethereum Network
Galaxy C$169.4 million offering of ordinary shares
We advised Galaxy on its offering
TD SYNNEX $600 million senior notes offering
The investment-grade notes are due 2034
Nippon Life Insurance $1.32 billion subordinated notes offering
We advised Nippon Life on its offering of step-up callable subordinated notes
Nurix Therapeutics $175 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market
Ultra Clean Holdings $500 million term loan facilities and related amendments
We advised the borrower on the transaction
Nuveen $1.25 billion senior notes offering
We advised Nuveen on the investment-grade debt offering